GeneDx Holdings Corp. (WGS NASDAQ) stock market data APIs
$137.0369
2.82(2.1%)
as of November 5, 2025
Try our APIs with
free plan!
GeneDx Holdings Corp. Financial Data Overview
Price chart is built with
Anychart
GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company also develops an AI-based platform for NGS analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. The company is headquartered in Stamford, Connecticut.
Prev. Close
137.0369
Open
139.8587
High
138.8456
Low
132.1837
52 wk Range
55.17-146
Market Cap
3 956 M
P/E Ratio
1244.2727
Shares Outstanding
28 905 K
Revenue
402 M
EPS
0.5
Beta
2.064
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with GeneDx Holdings Corp. (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get GeneDx Holdings Corp. data using free add-ons & libraries
Get GeneDx Holdings Corp. Fundamental Data
GeneDx Holdings Corp. Fundamental data includes:
- Net Revenue: 402 M
- EBITDA: 34 663 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-07-28
- EPS/Forecast: 0.118
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
GeneDx Holdings Corp. News
New
GeneDx to Participate in Upcoming Investor Conferences
GAITHERSBURG, Md., November 04, 2025--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will part...
3 Stocks Including FinWise Bancorp Estimated To Be Priced Below Intrinsic Value
As the United States stock market experiences a period of gains with major indices like the Nasdaq, S&P 500, and Dow Jones Industrial Average posting solid weekly and monthly increases, investors are ...
GeneDx Holdings Corp. (WGS) Q3 Earnings and Revenues Surpass Estimates
GeneDx Holdings Corp. (WGS) came out with quarterly earnings of $0.49 per share, beating the Zacks Consensus Estimate of $0.28 per share. This compares to earnings of $0.04 per share a year ago. These...
GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights
Reported third quarter 2025 revenues of $116.7 million with 65% year-over-year growth in exome and genome test revenue Accelerated exome and genome volume growth to 33% year-over-year Expanded adjuste...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
